Bräutigam K - Search Results

1

Detection and Specific Elimination of EGFR⁺ Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic Approach.

Bauerschlag D, Meinhold-Heerlein I, Maass N, Bleilevens A, Bräutigam K, Al Rawashdeh W, Di Fiore S, Haugg AM, Gremse F, Steitz J, Fischer R, Stickeler E, Barth S, Hussain AF. Bauerschlag D, et al. Among authors: brautigam k. Pharm Res. 2017 Apr;34(4):696-703. doi: 10.1007/s11095-017-2096-4. Epub 2017 Jan 10. Pharm Res. 2017. PMID: 28074431

2

An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.

Meinhold-Heerlein I, Bauerschlag D, Zhou Y, Sapinoso LM, Ching K, Frierson H Jr, Bräutigam K, Sehouli J, Stickeler E, Könsgen D, Hilpert F, von Kaisenberg CS, Pfisterer J, Bauknecht T, Jonat W, Arnold N, Hampton GM. Meinhold-Heerlein I, et al. Among authors: brautigam k. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):458-66. doi: 10.1158/1078-0432.CCR-06-0691. Clin Cancer Res. 2007. PMID: 17255266

3

Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation.

Bräutigam K, Bauerschlag DO, Weigel MT, Biernath-Wüpping J, Bauknecht T, Arnold N, Maass N, Meinhold-Heerlein I. Bräutigam K, et al. Transl Oncol. 2009 Aug 18;2(3):164-73. doi: 10.1593/tlo.09121. Transl Oncol. 2009. PMID: 19701501 Free PMC article.

4

Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.

Bräutigam K, Biernath-Wüpping J, Bauerschlag DO, von Kaisenberg CS, Jonat W, Maass N, Arnold N, Meinhold-Heerlein I. Bräutigam K, et al. J Cancer Res Clin Oncol. 2011 May;137(5):875-86. doi: 10.1007/s00432-010-0952-2. Epub 2010 Sep 29. J Cancer Res Clin Oncol. 2011. PMID: 20878528

5

Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles.

Bauerschlag DO, Ammerpohl O, Bräutigam K, Schem C, Lin Q, Weigel MT, Hilpert F, Arnold N, Maass N, Meinhold-Heerlein I, Wagner W. Bauerschlag DO, et al. Among authors: brautigam k. Oncology. 2011;80(1-2):12-20. doi: 10.1159/000327746. Epub 2011 May 16. Oncology. 2011. PMID: 21577013

6

Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary.

Bauerschlag D, Bräutigam K, Moll R, Sehouli J, Mustea A, Salehin D, Krajewska M, Reed JC, Maass N, Hampton GM, Meinhold-Heerlein I. Bauerschlag D, et al. Among authors: brautigam k. J Cancer Res Clin Oncol. 2013 Feb;139(2):347-55. doi: 10.1007/s00432-012-1334-8. Epub 2012 Oct 23. J Cancer Res Clin Oncol. 2013. PMID: 23090696

7

Breakpoint characterization of the der(19)t(11;19)(q13;p13) in the ovarian cancer cell line SKOV-3.

Onkes W, Fredrik R, Micci F, Schönbeck BJ, Martin-Subero JI, Ullmann R, Hilpert F, Bräutigam K, Janssen O, Maass N, Siebert R, Heim S, Arnold N, Weimer J. Onkes W, et al. Among authors: brautigam k. Genes Chromosomes Cancer. 2013 May;52(5):512-22. doi: 10.1002/gcc.22048. Epub 2013 Jan 30. Genes Chromosomes Cancer. 2013. PMID: 23362175

8

Reduced hemopexin levels in peritoneal fluid of patients with endometriosis.

Wölfler MM, Meinhold-Heerlein IM, Henkel C, Rath W, Neulen J, Maass N, Bräutigam K. Wölfler MM, et al. Among authors: brautigam k. Fertil Steril. 2013 Sep;100(3):777-81. doi: 10.1016/j.fertnstert.2013.05.010. Epub 2013 Jun 10. Fertil Steril. 2013. PMID: 23755951 Free article.

9

Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer.

Bauerschlag DO, Maass N, Leonhardt P, Verburg FA, Pecks U, Zeppernick F, Morgenroth A, Mottaghy FM, Tolba R, Meinhold-Heerlein I, Bräutigam K. Bauerschlag DO, et al. Among authors: brautigam k. J Transl Med. 2015 May 7;13:146. doi: 10.1186/s12967-015-0511-3. J Transl Med. 2015. PMID: 25947066 Free PMC article.

10

A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR.

von Felbert V, Bauerschlag D, Maass N, Bräutigam K, Meinhold-Heerlein I, Woitok M, Barth S, Hussain AF. von Felbert V, et al. Among authors: brautigam k. J Cancer Res Clin Oncol. 2016 May;142(5):1003-11. doi: 10.1007/s00432-016-2122-7. Epub 2016 Feb 3. J Cancer Res Clin Oncol. 2016. PMID: 26847542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters